Publicacións nas que colabora con Laura Muinelo Romay (28)

2024

  1. Role of cfDNA and ctDNA to improve the risk stratification and the disease follow-up in patients with endometrial cancer: towards the clinical application

    Journal of Experimental and Clinical Cancer Research, Vol. 43, Núm. 1

2023

  1. Ascites-Derived Organoids to Depict Platinum Resistance in Gynaecological Serous Carcinomas

    International Journal of Molecular Sciences, Vol. 24, Núm. 17

  2. Noninvasive detection of microsatellite instability in patients with endometrial cancer

    International Journal of Cancer, Vol. 152, Núm. 10, pp. 2206-2217

2022

  1. Improving the Management of Endometrial Cancer Patients through the Use of Liquid Biopsy Analyses: A Case Report

    International Journal of Molecular Sciences, Vol. 23, Núm. 15

  2. Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression

    Oncogene, Vol. 41, Núm. 13, pp. 1835-1850

  3. Liquid Biopsy for Monitoring EC Patients: Towards Personalized Treatment

    Cancers, Vol. 14, Núm. 6

2020

  1. Circulating Extracellular Vesicles in Gynecological Tumors: Realities and Challenges

    Frontiers in Oncology, Vol. 10

  2. Genomic profiling of uterine aspirates and cfDNA as an integrative liquid biopsy strategy in endometrial cancer

    Journal of Clinical Medicine, Vol. 9, Núm. 2

  3. Global gene expression characterization of circulating tumor cells in metastasic castration-resistant prostate cancer patients

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-14

2019

  1. Extracellular vesicles-based biomarkers represent a promising liquid biopsy in endometrial cancer

    Cancers, Vol. 11, Núm. 12

2018

  1. Liquid biopsy in endometrial cancer: New opportunities for personalized oncology

    International Journal of Molecular Sciences, Vol. 19, Núm. 8

2017

  1. Improving circulating tumor cells enumeration and characterization to predict outcome in first line chemotherapy mCRPC patients

    Oncotarget, Vol. 8, Núm. 33, pp. 54708-54721

  2. Predicting outcome and therapy response in mCRC patients using an indirect method for CTCs detection by a multigene expression panel: A multicentric prospective validation study

    International Journal of Molecular Sciences, Vol. 18, Núm. 6

2016

  1. EGFR-based immunoisolation as a recovery target for low-EpCAM CTC subpopulation

    PLoS ONE, Vol. 11, Núm. 10

  2. Molecular Profiling of Circulating Tumour Cells Identifies Notch1 as a Principal Regulator in Advanced Non-Small Cell Lung Cancer

    Scientific Reports, Vol. 6

2015

  1. Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer

    International Journal of Cancer, Vol. 136, Núm. 8, pp. 1863-1873

  2. Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasion

    Clinical and Experimental Metastasis, Vol. 32, Núm. 5, pp. 467-478

2014

  1. A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer

    International Journal of Cancer, Vol. 135, Núm. 11, pp. 2633-2643

  2. Biosensors for the detection of circulating tumour cells

    Sensors (Switzerland), Vol. 14, Núm. 3, pp. 4856-4875

  3. ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas

    Carcinogenesis, Vol. 35, Núm. 12, pp. 2679-2686